$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 11, 2025)
$55.72M
Market Cap
-
P/E Ratio
-1.62
EPS
$2.99
52 Week High
$0.87
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Adlai Nortye Ltd. is a clinical-stage biotechnology company focused on the research and development of innovative cancer therapies, primarily targeting opportunities in the United States and Mainland China. Headquartered in Grand Cayman, the firm is committed to leveraging cutting-edge scientific methodologies to meet significant unmet medical needs in oncology. With a strong and diverse pipeline, Adlai Nortye is strategically positioned to make a meaningful impact in the cancer treatment landscape, paving the way for potential collaborations and partnerships within the biopharmaceutical industry.
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
TSLA
KVUE
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
K
GOOGL
SOFI
WBD
RR
VALE
T
RGTI
BYND
NIO
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RIG
RKLB
JBLU
QBTS
AMD
CIFR
AG
CDE
MTSR
BTBT
SNAP
IREN
NCLH
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
KO
SMCI
WULF
LUV
UBER
CNQ
SOUN
SMR
CLSK
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
TSLA
KVUE
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
K
GOOGL
SOFI
WBD
RR
VALE
T
RGTI
BYND
NIO
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RIG
RKLB
JBLU
QBTS
AMD
CIFR
AG
CDE
MTSR
BTBT
SNAP
IREN
NCLH
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
KO
SMCI
WULF
LUV
UBER
CNQ
SOUN
SMR
CLSK